UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Medical Costs of CKD in the Medicare Population

Journal of the American Society of Nephrology, 2013-09, Vol.24 (9), p.1478-1483

2013

Volltextzugriff (PDF)

The Economic Burden of Vision Loss and Eye Disorders among the United States Population Younger than 40 Years

Ophthalmology (Rochester, Minn.), 2013-09, Vol.120 (9), p.1728-1735

2013

Volltextzugriff (PDF)

The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease

PloS one, 2016-07, Vol.11 (7), p.e0157323-e0157323

2016

Volltextzugriff (PDF)

16-OR: Cost-Effectiveness of the 2017 Hypertension Guidelines among U.S. Adults with Diabetes—Results from a Simulation Study

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults

Diabetes care, 2007-11, Vol.30 (11), p.2874-2879

2007

Volltextzugriff (PDF)

A Health Policy Model of CKD: 1. Model Construction, Assumptions, and Validation of Health Consequences

American journal of kidney diseases, 2010-03, Vol.55 (3), p.452-462

2010

Volltextzugriff (PDF)

Economics and Policy in Bariatric Surgery

Current diabetes reports, 2019-06, Vol.19 (6), p.29-6, Article 29

Hoerger, Thomas J.

2019

Volltextzugriff (PDF)

745-P: The Impact of COVID-19 and the Public Health Emergency on the Medicare Diabetes Prevention Program

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

In Reply to ‘The Myth of the Future Burden of CKD in United States’

American journal of kidney diseases, 2015-07, Vol.66 (1), p.172-172

2015

Volltextzugriff (PDF)

Impact Of The YMCA Of The USA Diabetes Prevention Program On Medicare Spending And Utilization

Health Affairs, 2017-03, Vol.36 (3), p.417-424

2017

Volltextzugriff (PDF)

Economic Costs Attributed to Diagnosed Diabetes in Each U.S. State and the District of Columbia: 2021

Diabetes care, 2024-08

2024

Volltextzugriff (PDF)

High-Risk Individuals' Willingness to Pay for Diabetes Risk-Reduction Programs

Diabetes care, 2006-06, Vol.29 (6), p.1351-1356

2006

Volltextzugriff (PDF)

Economic Costs Attributable to Diabetes in Each U.S. State

Diabetes care, 2018-12, Vol.41 (12), p.2526-2534

2018

Volltextzugriff (PDF)

State-level diabetes-attributable mortality and years of life lost in the United States

Annals of epidemiology, 2018-11, Vol.28 (11), p.790-795

2018

Volltextzugriff (PDF)

Postdelivery Intervention to Prevent Type 2 Diabetes and the Cost-Effectiveness of Screening Criteria for Gestational Diabetes

Preventing chronic disease, 2022-12, Vol.19, p.E89-E89, Article 220055

2022

Volltextzugriff (PDF)

171-OR: Preventing Diabetes: Resource Allocation between Risk-Based and Whole Population–Based Approaches

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

177-OR: Estimating the Costs of Diabetes Complications in People <65 Years in the U.S. Using Panel Data

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Cost-effectiveness of patient navigation for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program

Cancer causes & control, 2019-09, Vol.30 (9), p.923-929

2019

Volltextzugriff (PDF)

Use of Econometric Models to Estimate Expenditure Shares

Health services research, 2008-08, Vol.43 (4), p.1442-1452

2008

Volltextzugriff (PDF)

Patient Health Utility Equations for a Type 2 Diabetes Model

Diabetes care, 2021-02, Vol.44 (2), p.381-389

2021

Volltextzugriff (PDF)

Cost‐effectiveness of scaling‐up HCV prevention and treatment in the United States for people who inject drugs

Addiction (Abingdon, England), 2019-12, Vol.114 (12), p.2267-2278

2019

Volltextzugriff (PDF)

1536-P: Parametric Survival Analysis of Complications from Type 1 Diabetes

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

146-OR: A New Type 2 Diabetes Microsimulation Model to Estimate Long-Term Health Outcomes, Costs, and Cost-Effectiveness

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

Alternative HbA1c Cutoffs to Identify High-Risk Adults for Diabetes Prevention

American journal of preventive medicine, 2012-04, Vol.42 (4), p.374-381

2012

Volltextzugriff (PDF)

Impact of Financial Incentives on Service Use, Spending, and Health in Medicaid

American journal of preventive medicine, 2018-12, Vol.55 (6), p.875-886

2018

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(82)

Sprache

Englisch
(82)

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(44)
Humans
(40)
Diabetes
(19)
United States
(18)
Cost-Benefit Analysis
(17)
Public, Environmental & Occupational Health
(16)
Health Care Sciences & Services
(13)
Female
(12)
Health Policy & Services
(12)
Economics
(11)
Quality-Adjusted Life Years
(11)
Studies
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Medicare
(10)
Cost Analysis
(9)
Diabetes Mellitus
(9)
Endocrinology & Metabolism
(9)
Health Care Costs
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Medical Costs of CKD in the Medicare Population

The Economic Burden of Vision Loss and Eye Disorders among the United States Population Younger than 40 Years

The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease

16-OR: Cost-Effectiveness of the 2017 Hypertension Guidelines among U.S. Adults with Diabetes—Results from a Simulation Study

Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults

A Health Policy Model of CKD: 1. Model Construction, Assumptions, and Validation of Health Consequences

Economics and Policy in Bariatric Surgery

745-P: The Impact of COVID-19 and the Public Health Emergency on the Medicare Diabetes Prevention Program

In Reply to ‘The Myth of the Future Burden of CKD in United States’

Impact Of The YMCA Of The USA Diabetes Prevention Program On Medicare Spending And Utilization

Economic Costs Attributed to Diagnosed Diabetes in Each U.S. State and the District of Columbia: 2021

High-Risk Individuals' Willingness to Pay for Diabetes Risk-Reduction Programs

Economic Costs Attributable to Diabetes in Each U.S. State

State-level diabetes-attributable mortality and years of life lost in the United States

Postdelivery Intervention to Prevent Type 2 Diabetes and the Cost-Effectiveness of Screening Criteria for Gestational Diabetes

171-OR: Preventing Diabetes: Resource Allocation between Risk-Based and Whole Population–Based Approaches

177-OR: Estimating the Costs of Diabetes Complications in People <65 Years in the U.S. Using Panel Data

Cost-effectiveness of patient navigation for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program

Use of Econometric Models to Estimate Expenditure Shares

Patient Health Utility Equations for a Type 2 Diabetes Model

Cost‐effectiveness of scaling‐up HCV prevention and treatment in the United States for people who inject drugs

1536-P: Parametric Survival Analysis of Complications from Type 1 Diabetes

146-OR: A New Type 2 Diabetes Microsimulation Model to Estimate Long-Term Health Outcomes, Costs, and Cost-Effectiveness

Alternative HbA1c Cutoffs to Identify High-Risk Adults for Diabetes Prevention

Impact of Financial Incentives on Service Use, Spending, and Health in Medicaid

Aktive Filter

Suchergebnisse filtern